News & Updates

The U.S. Food and Drug Administration has granted 510(k) clearance for the PreemptiveAI Clinical SDK (K250233), validating our core physiological modeling technology as a Class II medical device. This milestone confirms our software's substantial equivalence to predicate devices, enabling clinical-grade monitoring at scale.

We are establishing our first dedicated clinical practice in Florida, allowing members to access full longitudinal care directly through Preemptive.

In a retrospective study involving 200 patients, Preemptive's physiological modeling identified risk signals 72 hours prior to readmission events with 84.7% AUC.

Axios reports on Preemptive's seed funding round led by existing investors to build the first biomedical foundation model for predictive health.

Official announcement of our launch and vision to shift healthcare from reactive to proactive using advanced physiological modeling.

MultiCare Health System joins Preemptive as a strategic investor through MultiCare Ventures, validating the need for a new physiological monitoring layer to support value-based care.

Why we are moving from episodic snapshots to continuous physiological understanding, and what it means for the future of primary care.